C09CA04 · Cardiovascular system
Irbesartan Zentiva (previously Irbesartan Winthrop)
Indications
Treatment of essential hypertension. Treatment of renal disease in patients with hypertension and type-2 diabetes mellitus as part of an antihypertensive medicinal-product regimen.
Composition
- Active substance
- irbesartan
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Irbesartan Zentiva (previously Irbesartan Winthrop)
- Active substance
- irbesartan
- ATC code
- C09CA04
- Therapeutic area
- Hypertension
- Marketing authorisation holder
- Zentiva k.s.
- Status
- Authorised
- EU authorisation